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Safe, cost-effective management of patients presenting to
the emergency department (ED) because of chest pain
compatible with myocardial ischemia continues to present a
major clinical challenge. Current standards mandate rapid
institution of proven therapy for reduction of mortality and
morbidity in patients with acute coronary syndromes. How-
ever, in most patients presenting to the ED with chest pain,
this symptom is related to disorders without fatal potential,
such as musculoskeletal, gastroesophageal or anxiety syn-
dromes (1), in which an erroneous impression of myocardial
ischemia can prompt unwarranted hospital admission, re-
sulting in unnecessary tests and major costs. The balance of
these opposing factors has traditionally favored a low
threshold for admission for chest pain of possible cardiac
origin because of primary concern for patient welfare, as well
as litigation potential for failure to detect a coronary event.
This approach is consistent with the directive of early
innovators of the coronary care unit (CCU) that “patients
should be admitted to the CCU solely on suspicion of
having an acute myocardial infarction” (2). A low threshold
for admission of these patients has also been supported by
reports of at least a 2% rate of missed ACS in patients
discharged from the ED (3).
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Underscoring this problem are data showing that failure
to diagnose myocardial infarction (MI) is the leading cause
of malpractice awards against emergency medicine physi-
cians, accounting for 21% of total litigation costs to this
group (4). However, application of a low threshold for
admission has resulted in annual hospitalization of millions
of patients in whom a coronary event is diagnosed in ,20%
(5) at a cost of more than $10 billion (6). The term “rule-out
myocardial infarction,” or “ROMI,” has traditionally been
applied to patients admitted for findings suggestive, but not
diagnostic, of acute MI, and these patients comprise the
great majority of those admitted for evaluation of chest pain.
Studies during the last several decades have demonstrated
that low-risk patients presenting with chest pain can be
recognized by clinical criteria, including the history, physical
examination and initial electrocardiogram (ECG) (7,8).
Management of these patients differs fundamentally from
that of high-risk patients who require urgent initiation of
time-dependent coronary reperfusion therapy and other
anti-ischemic modalities. To fulfill the dichotomous thera-
peutic requirements of both high- and low-risk patients
presenting with chest pain, innovative strategies have been
developed that include management guidelines, clinical
algorithms, predictive instruments and, more recently, chest
pain observation units (CPU) (9–12). The objectives of the
CPU are 1) triage of high-risk patients into fast-track
therapy, and 2) recognition of low-risk patients for assign-
ment to more deliberate evaluation and treatment. Avoid-
ance of unnecessary admissions is a major goal in the latter
group. Current strategies entail accelerated diagnostic pro-
tocols comprising 6 to 12 h of monitoring and measurement
of cardiac injury markers, which, if negative, are followed by
exercise testing before or shortly after discharge (9,12).
Further innovations include immediate exercise testing of
low-risk patients who are discharged if the test is negative
(12) and rest perfusion scintigraphy in the ED to identify
patients who do not require admission. Outpatient
follow-up is an intrinsic component of these strategies.
In this issue of the Journal, deFilippi et al. (13) address
the questions of: 1) whether CPUs staffed by ED physicians
adequately test for the presence of coronary artery disease,
and 2) whether an invasive approach will lead to fewer
unnecessary readmissions. Answers to these important
questions will help define the role of CPUs in the manage-
ment of low-risk patients presenting to the ED with acute
chest pain.
First, is it essential for a CPU to absolutely exclude the
presence of coronary disease, or should the unit’s primary
function be exclusion of moderate- to high-risk disease in
which immediate intervention is likely to be beneficial to the
patient? In patients who present with chest pain identified
as low risk, the likelihood of a cardiac origin of the symptom
is ,7% (10). Therefore, the probability is .90% that the
chest pain in these low-risk patients is due to a noncardiac
etiology, with gastroesophageal reflux disease, panic attack,
pancreatitis, gallstones and costochondritis among the lead-
ing possibilities (1).
Second, to what extent is it reasonable to expose a patient
to a procedure with a low, but definite risk, such as cardiac
catheterization, to exclude a disease with a very low proba-
bility? In addition, angiographic identification of coronary
disease does not establish the etiology of a low-risk patient’s
chest pain. Therefore, it is possible that routine angiography
could lead to misdiagnosis and unnecessary interventions.
Once a patient has been stratified to low risk, the decision
to proceed with further diagnostic tests would seem to be
best reserved for the patient’s primary care physician or
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cardiologist and not an issue to be thrust upon a physician
in an ED.
To address these questions, deFilippi et al. (13) random-
ized 248 selected low-risk chest pain patients (,65 years
old, no history of coronary artery disease, benign ECG) who
were admitted to their CPU by ED physicians and ruled out
for MI, to either cardiac catheterization or predischarge
treadmill testing for further risk stratification. Routine
cardiac catheterization was performed in 123 patients, of
whom 23 had .50% stenosis in one or more epicardial
vessels. Of the 125 patients who were randomized to
predischarge treadmill testing, 9 had positive tests. The
percentage of patients with angiographically documented
coronary disease was significantly greater than the propor-
tion with positive treadmill tests (19% vs. 7%, p , 0.018).
This result is consistent with the recognized superior
sensitivity of coronary angiography to exercise testing for
detecting coronary disease. The sensitivity of treadmill
testing in this study may have been further reduced because
34% of patients did not achieve target heart rate and in 15%
the exercise heart rate was ,75% of age-predicted maxi-
mum. However, it does not follow that, in all patients with
angiographically detectable disease, chest pain was due to
cardiac ischemia; coronary disease may coexist with noncar-
diac causes of chest pain. But, as the investigators point out,
making the diagnosis of subclinical coronary disease may
allow for medical intervention that could reduce the risk of
future events.
In the study by deFilippi et al. (13), detection of coronary
disease by randomization to angiography resulted in 3
coronary artery bypass surgeries, 11 percutaneous coronary
interventions, 1 MI and no deaths. Detection of cardiac
ischemia by routine treadmill testing was followed by 12
cardiac catheterizations, 5 percutaneous interventions, 1
coronary bypass surgery and no MI or deaths. After one year
of follow-up, randomization to angiography was associated
with 111 more cardiac catheterizations, 8 more revascular-
ization procedures and the only MI. This resulted in 23
fewer ED revisits and 15 fewer admissions among patients
with negative cardiac catheterizations compared to those
with negative exercise tests. Furthermore, the investigators
do not report the number of revisits or readmissions in
patients with angiographic disease or positive treadmill
tests. It is possible that detection of subclinical angiographic
disease in this group may lead to more admissions and offset
some of the savings when compared to the negative group.
As the investigators note, lack of net benefit in perform-
ing routine angiography and interventions in low- to
moderate-risk coronary disease patients is consistent with
other randomized studies of invasive versus noninvasive
management (14,15). In the second Randomized Interven-
tion Treatment of Angina (RITA-2) trial, coronary inter-
vention was superior to medical therapy in terms of angina
and exercise test performance (16). However, there was also
a 3% excess rate of MI in the intervention group, of which
1.4% were procedure-related. In a subsequent study, the
RITA investigators reported a greater improvement in
quality of life measures in the intervention patients (17), but
this difference was no longer significant after three years.
These data suggest that routine angiography and interven-
tion result in short-term improvement in quality of life at a
cost of increased MI. Extrapolating these outcomes to
low-risk CPU patients, it is reasonable to conclude that
increasing the diagnostic certainty of coronary disease by
performing routine angiography may afford short-term
quality of life benefit (e.g., fewer return visits to the ED) at
the cost of increased revascularization, MI and death from
unnecessary procedures.
The answer to the question of whether routine angiog-
raphy in the CPU will lead to fewer unnecessary admissions
seems affirmative at first glance, but there may be less costly
options. In the current study, deFilippi et al. (13) reported
that patients randomized to initial evaluation with treadmill
testing compared to angiography had more subsequent ED
visits (26% vs. 8%) and admissions (14% vs. 2%). These
results are consistent with the investigators’ conclusion that
diagnostic uncertainty results in greater recidivism and
higher admission rates. These findings are also concordant
with our data in 422 consecutive low-risk chest pain patients
revealing that 11% of patients with a negative treadmill
return to the ED with chest pain during a one-year
follow-up (18).
However, the CPU does not operate independently of
good medical care, but is instead only one component of the
medical system. First, burdening the CPU with the respon-
sibility of the decision to perform an invasive diagnostic
evaluation may be inappropriate. Also, concluding that the
CPU is solely responsible for solving a high rate of recidi-
vism may be premature. When patients leave the CPU with
a negative or low-risk nondiagnostic evaluation, they may be
informed that the symptom is not likely due to heart disease.
Upon discharge, they may or may not be given instructions
to return to their primary care physician for further evalu-
ation. Failure to discover the etiology of chest pain at the
initial evaluation is not completely reassuring, and when the
chest pain recurs, patients will naturally seek further medical
attention. Therefore, the rate of recidivism is highly depen-
dent not only on excluding a cardiac diagnosis, but also on
establishing a diagnosis and applying appropriate therapy.
In selecting an initial diagnostic strategy, it is also
essential to recognize that, although coronary angiography
is superior to noninvasive testing for detecting coronary
disease, it is not superior for predicting risk. In a study of
115 post-MI patients followed for five years, submaximal
exercise testing was as accurate as coronary arteriography in
identifying patients at risk for complications (19). Measures
of regional wall motion abnormalities by echocardiography
or radionuclide ventriculography were even more predictive
of complications.
deFilippi et al. (13) do not state whether patients with a
low-risk evaluation received follow-up appointments to
their primary care physicians or referrals to a cardiologist
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after discharge from the CPU. The reasons for readmission
are also unclear. Patients returning to our CPU have a
higher rate of psychosocial symptoms (anxiety, panic, de-
pression) compared to those who do not return (22% vs. 8%)
during the year after initial evaluation (19). High rates of
recidivism may not be due to inadequate CPU evaluation,
but rather to lack of outpatient follow-through. Ruling out
MI or unstable angina in the CPU should not be considered
a diagnostic end point. Failure to make a diagnosis of
cardiac disease in the CPU is only the first step in the
patient’s evaluation. Not completing that evaluation may be
where we fail our patients. Outpatient chest pain clinics for
investigation of both cardiac and noncardiac causes of chest
pain may be the next step in the evolution of the CPU.
Finally, deFilippi et al. (13) have addressed an important
clinical question with a rigorous, well-conducted trial, and
their work will undoubtedly stimulate significant contro-
versy. They have demonstrated that the prevalence of
coronary disease in the CPU population is considerably
greater than noninvasive testing suggests. They have also
demonstrated that rate recidivism to the ED in this low-risk
population is lower in patients with an invasive approach. It
is clear that the final word on the management of low-risk
patients presenting to the ED with chest pain has not yet
been heard.
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